Published in Ann Soc Belg Med Trop on September 01, 1984
Ecological niche and geographic distribution of human monkeypox in Africa. PLoS One (2007) 1.41
A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012. Future Virol (2013) 1.01
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods (1988) 7.74
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature (1990) 5.70
Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol (1968) 3.29
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1988) 2.82
Airport malaria in Belgium. Lancet (1982) 2.70
An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives. Proc Natl Acad Sci U S A (1991) 2.37
Letter: Keratoconjunctivitis caused by Adenovirus Type 19. Br Med J (1974) 2.36
Antibiotic susceptibility of Neisseria gonorrhoeae strains from Europe and Africa. Antimicrob Agents Chemother (1979) 2.31
Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro. Antimicrob Agents Chemother (1987) 2.24
Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. Gastroenterology (1976) 2.17
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents. Antimicrob Agents Chemother (1988) 2.16
Yersinia enterocolitica infections and pork: the missing link. Lancet (1987) 2.15
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538). AIDS (1996) 2.14
Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus. J Virol Methods (1987) 2.10
Evaluation of six enzyme immunoassays for antibody against human immunodeficiency virus. Lancet (1986) 2.04
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations. J Acquir Immune Defic Syndr (1999) 1.88
The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol (1977) 1.86
The IgM antibody response in rubella during pregnancy. J Med Microbiol (1971) 1.85
Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother (1977) 1.79
Population genetic studies in the Congo. I. Glucose-6-phosphate dehydrogenase deficiency, hemoglobin S, and malaria. Am J Hum Genet (1966) 1.72
Mycobacteria, skins, and needles. Lancet (1969) 1.70
Enterovirus 70 haemorrhagic conjunctivitis in Zäire, 1981 versus 1972. Lancet (1981) 1.68
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Biochem Biophys Res Commun (1987) 1.67
Plasmid characterisation in the investigation of an epidemic caused by multiply resistant Shigella dysenteriae type 1 in Central Africa. Lancet (1981) 1.65
The association of gonorrhoea and syphilis with premature birth and low birthweight. Genitourin Med (1993) 1.65
Serologic diagnosis and fetal involvement in maternal rubella. Criteria for abortion. JAMA (1968) 1.61
Community-acquired bacteraemia in African children. Lancet (1987) 1.61
Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.60
Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain. J Infect Dis (1996) 1.58
A primate T-lymphotropic virus, PTLV-L, different from human T-lymphotropic viruses types I and II, in a wild-caught baboon (Papio hamadryas). Proc Natl Acad Sci U S A (1994) 1.55
Frequent isolation of Edwardsiella tarda and Pleisiomonas shigelloides from healthy Zairese freshwater fish: a possible source of sporadic diarrhea in the tropics. Appl Environ Microbiol (1980) 1.55
Subacute bacterial endocarditis due to Actinobacillus actinomycetemcomitans. Report of a case with a review of the literature. J Clin Pathol (1977) 1.55
Nonvalue of cold enrichment of stools for isolation of Yersinia enterocolitica serotypes 3 and 9 from patients. J Clin Microbiol (1980) 1.54
Rubella virus neutralization by plaque reduction. Proc Soc Exp Biol Med (1967) 1.53
Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology (1990) 1.53
A human interferon that crosses the species line. Proc Natl Acad Sci U S A (1968) 1.52
Polyacetal carboxylic acids: a new group of antiviral polyanions. J Virol (1970) 1.51
Antiviral activity of chlorite-oxidized oxyamylose, a polyacetal carboxylic acid. J Virol (1970) 1.46
Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain. AIDS Res Hum Retroviruses (1998) 1.46
Cryptosporidium spp., a frequent cause of diarrhea in Central Africa. J Clin Microbiol (1984) 1.44
Yersinia enterocolitica in donor blood: a case report and review. J Clin Microbiol (1989) 1.44
The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae. J Infect Dis (1994) 1.43
Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients. J Clin Pathol (1976) 1.41
Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis. Virology (1992) 1.38
Isolation of Yersinia enterocolitica serotype 0: 3 from captive monkeys and domestic pigs in Zaire. Ann Soc Belg Med Trop (1978) 1.37
[Isolation of Yersinia enterocolitica by a routine coproculture technic]. Ann Inst Pasteur (Paris) (1968) 1.36
Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology. J Med Virol (1997) 1.36
Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc Natl Acad Sci U S A (1989) 1.33
AIDS and cryptococcosis (Zaire, 1977) Lancet (1983) 1.32
Yersinia enterocolitica: its isolation by cold enrichment from patients and healthy subjects. J Clin Pathol (1981) 1.31
Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet (1976) 1.31
Fatal leishmaniasis in renal-transplant patient. Lancet (1979) 1.30
Tempo and mode of human and simian T-lymphotropic virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences. Mol Biol Evol (2000) 1.30
In vitro antimicrobial sensitivity of Neisseria gonorrhoeae from Rwanda. Genitourin Med (1986) 1.29
Acquisition of trimethoprim resistance in epidemic strain of Shigella dysenteriae type 1 from Zaire. Lancet (1982) 1.26
Interferon in congenital rubella: response to live attenuated measles vaccine. J Immunol (1967) 1.26
Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis. Virology (1992) 1.26
Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir). Mol Pharmacol (1998) 1.25
Pseudomonas putrefaciens as a cause of infection in humans. J Clin Pathol (1975) 1.25
The simian origins of the pathogenic human T-cell lymphotropic virus type I. Trends Microbiol (1998) 1.24
Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc Natl Acad Sci U S A (1999) 1.24
Molecular heterogeneity of human leukocyte interferon: two populations differing in molecular weights, requirements for renaturation, and cross-species antiviral activity. Virology (1975) 1.23
Letter: Primary amoebic meningoencephalitis after swimming in stream water. Lancet (1973) 1.22
Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection. Clin Diagn Virol (1997) 1.20
Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein. Mol Pharmacol (1997) 1.20
Syphilis in Swaziland: a serological survey. Br J Vener Dis (1981) 1.20
Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res (1992) 1.19
Evaluating Clinical Isolates for Their Phenotypic and Genotypic Resistance Against Anti-HIV Drugs. Methods Mol Med (2000) 1.19
Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial. Lancet (1983) 1.17
Haemorrhagic colitis and verotoxin-producing Escherichia coli O157 in Belgium. Lancet (1987) 1.17
Widespread occurrence of multiple drug-resistant Salmonella typhi in India. Eur J Clin Microbiol Infect Dis (1992) 1.16
Molecular modification of interferon: attainment of human interferon in a conformation active on cat cells but inactive on human cells. Virology (1976) 1.16
Laboratory rat associated outbreak of haemorrhagic fever with renal syndrome due to Hantaan-like virus in Belgium. Lancet (1984) 1.15
The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports an African origin for the human T-lymphotropic/simian T-lymphotropic group of viruses. J Gen Virol (1996) 1.15
Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma. Br J Cancer (1980) 1.14
Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries. AIDS (1998) 1.14
Infections caused by Kingella kingae: report of four cases and review. J Infect (1986) 1.13
A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution. J Neurol Neurosurg Psychiatry (1990) 1.13
Lactobacilli in Papanicolaou smears, genital infections, and pregnancy. Am J Perinatol (1993) 1.13
Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Antimicrob Agents Chemother (1986) 1.13
HTLV-II among pygmies. Nature (1992) 1.12
[Shigellosis in Kinshasa. Bacteriologic and epidemiologic data collected over an 8-year period]. Med Trop (Mars) (1973) 1.12
Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium. Dev Biol Stand (1979) 1.12
New enrichment method for isolation of pathogenic Yersinia enterocolitica serogroup O:3 from pork. Appl Environ Microbiol (1988) 1.12
Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J Virol Methods (1995) 1.11
Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi. Cytopathology (2006) 1.11
Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid. Proc Natl Acad Sci U S A (1972) 1.11
New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase. Antiviral Res (1996) 1.09
Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. Eur J Clin Microbiol Infect Dis (1995) 1.09
Autochtonous falciparum malaria in Belgium. Ann Soc Belg Med Trop (1983) 1.09
Two new human T-lymphotropic virus type I phylogenetic subtypes in seroindeterminates, a Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I strains. Virology (1998) 1.08
Epidemiological and clinical aspects of human Yersinia enterocolitica infections in Belgium. Contrib Microbiol Immunol (1979) 1.08
Endocarditis caused by nutritionally deficient streptococci. Acta Clin Belg (1983) 1.08
Pseudomonas putrefaciens as a cause of bacteremia in humans. J Clin Microbiol (1978) 1.07
Cases of Mycobacterium borstelense and M. abscessus infection observed in Belgium. J Med Microbiol (1971) 1.07
Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients. Lancet (1975) 1.07